Curesign is a medical device company which aims to disrupt the way oncologists treat cancer patients. Our solution is based on integrating state-of-the-art sensors with the most advanced signal processing and big data tools. Our product, which is currently in advanced stages of development, will allow the clinical team to tailor a patient specific treatment for each cancer patient.
The Curesign technology was successfully demonstrated in preclinical studies. Based on our results, we are working on a commercial product which could be used in many preclinical trials in the field of oncology.
If you’d like to learn more email us at [email protected]